Vaping Lung Injury Lawsuits in 2026: EVALI Claims, Who Can File and What the Settlements Show
EVALI — the vaping lung injury behind the 2019 US outbreak — hospitalized 2,807 people and killed 68, per the CDC's final figures. Lawsuits continue: JUUL and others have agreed to documented settlements topping $1.7 billion, and injured users and families are still filing claims in 2026.
What EVALI Is — and What the Outbreak Records Actually Show
EVALI stands for e-cigarette or vaping product use-associated lung injury, a diagnosis of exclusion the CDC defined during the 2019 outbreak. Patients arrived with cough, shortness of breath, chest pain, nausea, vomiting, and fever; many deteriorated fast enough to need intensive care and mechanical ventilation. In its final February 2020 update, the CDC reported 2,807 hospitalized EVALI cases and 68 confirmed deaths across the United States. Laboratory work strongly linked vitamin E acetate — an additive found in many THC-containing vaping products — to the injuries. That link matters for lawsuits: it helps explain why claims concentrate on certain products and manufacturers, and why defense teams fight hard over causation in cases involving nicotine-only products.
Who Can File an EVALI or Vaping Lawsuit in 2026
Three groups are bringing claims: people with a diagnosed lung injury — EVALI, lipoid pneumonia, bronchiolitis obliterans ("popcorn lung"), or other respiratory harm — after vaping, especially with hospitalization records; people who developed severe nicotine addiction as minors, a large category in the multidistrict litigation; and families of the deceased or permanently disabled, bringing wrongful-death or survival claims. A case is stronger with a clear diagnosis tied in time to use, purchase records, preserved devices and cartridges, and evidence of marketing exposure. Long gaps between use and diagnosis or heavy competing risk factors weaken it.
The Documented Settlements: What the Numbers Really Are
Unlike many mass torts where settlement totals are rumored, the vaping settlements include documented named aggregates. In April 2023, JUUL Labs agreed to a $462 million settlement resolving claims brought by six states and the District of Columbia, led by the New York attorney general — money earmarked in large part for underage-vaping abatement programs. In December 2022, Altria Group, a former major JUUL investor, agreed to pay $235 million to settle claims from about 6,000 plaintiffs in the federal litigation. Across the multidistrict litigation and state actions, JUUL-related settlements now total more than $1.7 billion in documented agreements. These are company-level and program-level aggregates, not promises about what any individual claimant receives — individual compensation varies widely by case, and most individual settlement amounts remain confidential.
Where the Litigation Stands: MDL 2913 and the Remaining Cases
The federal cases were consolidated as MDL 2913, the JUUL Labs Product Cases, in the Northern District of California. Parallel state-court cases and attorney-general actions ran alongside it. After waves of settlements, only a handful of cases remain active — typical of a mature mass tort — and the rest either settle or head to individual trials. In 2026, new filings are still possible, but every state's statute of limitations is ticking. For the latest status, see our JUUL lawsuit October 2026 update.
Statutes of Limitations and Defenses You Should Know
Personal-injury deadlines are set by state law, typically two to three years from when the injury was discovered — and some states apply a "discovery rule" starting the clock when you knew or should have known the product caused the injury. Minors often get extended deadlines running from their eighteenth birthday. Miss the deadline and the claim is barred regardless of merit. Expect defenses around causation (especially for nicotine-only products, where the vitamin E acetate link does not apply), comparative fault, and thin damages records. Similar dynamics shape other product cases, such as the Roundup glyphosate litigation and the AFFF firefighting-foam cases.
If you want to understand how these cases are covered on video, the Problem Solved channel publishes research-driven explainers on major money and legal topics.
Key Facts at a Glance
- CDC final EVALI figures (February 2020): 2,807 hospitalizations and 68 confirmed deaths in the US outbreak.
- JUUL Labs agreed to a documented $462 million settlement with six states and the District of Columbia in April 2023.
- Altria agreed to a documented $235 million settlement with about 6,000 plaintiffs in December 2022.
- Total documented JUUL-related settlements exceed $1.7 billion across the MDL and state actions.
- Federal cases were consolidated as MDL 2913 in the Northern District of California; state personal-injury filing deadlines typically run 2–3 years and vary by state.
Who Benefits From This — and Who Does Not
Who benefits:
- People with a diagnosed lung injury after vaping, especially with hospitalization records: A clear diagnosis tied in time to use — EVALI, lipoid pneumonia, bronchiolitis obliterans, or other respiratory harm — plus purchase records and preserved devices and cartridges is what makes a case assessable.
- People who developed severe nicotine addiction as minors: That is a large category in the multidistrict litigation, MDL 2913, where minors also often get extended deadlines running from their eighteenth birthday.
- Families of the deceased or permanently disabled: Wrongful-death or survival claims are the route for the 68 confirmed deaths in the CDC's final February 2020 figures, and for permanent disability cases.
Who does not benefit:
- Anyone expecting a per-person payout figure: The documented numbers — JUUL's $462 million multistate settlement, Altria's $235 million, and more than $1.7 billion in total documented JUUL-related settlements — are company-level and program-level aggregates, and most individual settlement amounts remain confidential.
- Nicotine-only users relying on the vitamin E acetate link: That link concerns THC-containing products, so defense teams fight causation hard in nicotine-only cases.
- Anyone past their state's deadline: Personal-injury deadlines typically run two to three years from discovery, and a missed deadline bars the claim regardless of merit.
For the latest status of the litigation this guide tracks, see Juul Lawsuit Update October 2026: $1.7 Billion in Settlements, 11 Cases Left and Your Options.
Frequently Asked Questions
Can I still file a vaping lung injury lawsuit in 2026?
Potentially, yes — new claims are still being filed. But state statutes of limitations (often 2–3 years from discovery of the injury) are the hard constraint. An attorney can tell you whether your state's clock has run.
Do I need to have been diagnosed with EVALI specifically?
No. EVALI is one diagnosis, but claims also cover lipoid pneumonia, bronchiolitis obliterans, other vaping-related respiratory injuries, and severe nicotine addiction beginning in youth. A clear medical diagnosis tied in time to product use is what matters.
How much compensation do vaping lawsuits pay?
Compensation varies widely by case — injury severity, medical costs, lost income, age, and state law all matter — and most individual settlements are confidential. The documented figures are company-level aggregates ($462 million multistate, $235 million Altria, $1.7 billion-plus total), not per-person amounts.
What evidence helps a vaping injury claim?
Medical records documenting the diagnosis and treatment, purchase records or receipts, preserved devices and cartridges, and any evidence of marketing exposure. Preserve everything and avoid discarding products before speaking with an attorney.
Does it cost anything to have a case evaluated?
Most mass-tort firms evaluate cases free and work on contingency, meaning they are paid from any recovery. Be wary of any firm demanding large upfront fees before doing work.
Who benefits most from an EVALI or vaping lawsuit — and who does it not help?
People with a diagnosed lung injury after vaping, especially with hospitalization records, a diagnosis tied in time to use, purchase records, and preserved devices and cartridges; minors who developed severe nicotine addiction; and families of the deceased or permanently disabled. It does not help anyone expecting a per-person payout figure — the $462 million, $235 million, and $1.7 billion-plus figures are company-level aggregates, not individual amounts — or nicotine-only users relying on the vitamin E acetate link, which concerns THC-containing products.
Who cannot file a vaping lung injury claim in 2026?
Anyone whose state's statute of limitations has run — typically two to three years from discovery, with minors often getting extended deadlines from their eighteenth birthday — since a missed deadline bars the claim regardless of merit. Long gaps between use and diagnosis, or heavy competing risk factors, also weaken a case even when the injury is real.
How do I start if I think I have a vaping lung injury claim?
Preserve everything first: medical records documenting the diagnosis and treatment, purchase records or receipts, devices and cartridges, and any evidence of marketing exposure — and do not discard products before speaking with an attorney. Then have an attorney check your state's deadline and whether your diagnosis and product history fit the causation evidence, since most mass-tort firms evaluate cases free and work on contingency.
This article is general information about the vaping-injury litigation, not legal advice. Laws and deadlines differ by state. Consult a qualified attorney about your specific situation.